<DOC>
	<DOC>NCT00180375</DOC>
	<brief_summary>This study evaluates the date of the first appropriate and/or inappropriate therapy in patients implanted with a Guidant PRIZM or VITALITY defibrillator and is evaluating eventual predictive risk factors for appropriate/inappropriate therapies as well as the influence of the programmed parameters on these therapies.</brief_summary>
	<brief_title>OPERA: French Observational Study on Patients Implanted With a Guidant PRIZM or Vitality Defibrillator</brief_title>
	<detailed_description>The registry measured the times to, and studied the determinants of, first appropriate (FAT) and inappropriate (FIT) therapy delivered by single, dual and triple chamber (CRT-D) ICD implanted for primary and secondary prevention indications.</detailed_description>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia, Ventricular</mesh_term>
	<mesh_term>Ventricular Fibrillation</mesh_term>
	<criteria>Indication for an ICD according to current guidelines, incl. prophylactic indication pregnant or at birth bearing age without contraception, participation in another clinical trial, short life expectancy, geographically unstable for a followup at the investigational center</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>